Avgi Mamalaki is Research Director HPI, Head of Molecular Biology & Immunobiotechnology Laboratory. She received the Biology degree ("Babes-Bolyai" University, Cluj-Napoca, Romania, 1980), and the D.E.R.B.H. (Diploma des Etudes et de Recherche en Biologie Humaine) and Doctorat d'Etat en Biologie Humaine (Medical School of the University Paris XII "Val-de-Marne", France). She was a post-doctoral researcher in the IMBB, FORTH, Heraclion Crete. She was a visiting researcher in the National Cancer Institute (NCI-FCRDC), Frederick, Maryland, USA, in the laboratory of Human Retroviruses. Since 1990 she has been in HPI. In the recent years, her research interests focuses on exploring the molecular mechanisms involved in hepcidin regulation and the development of immunodiagnostic and immunotherapeutic agents (with emphasis on recombinant human antibodies). She has received and coordinated a large number of funding. She has 3 international patents.

Dr. Alexios Dimitriadis is a post-doctorate research associate at the Hellenic Pasteur Institute. He holds a bachelors’ degree in Biology from the National and Kapodistrian University of Athens, and a doctorate in Medicine from the same university. He has contributed in projects funded by the European Union and the National Strategic Reference Framework, in regards to the study of possible immunotherapeutic methods against Her2/neu positive cancer and the investigation of the pathogenetic role of hepcidin in iron-related diseases. Additionally, he received a scholarship from the State Scholarships Foundation for his study of new biomarkers in Hepatocellular carcinoma. He has published articles in science journals and conference proceedings and has taken part in presentations, seminars and workshops.

No CV provided

No CV provided

No CV provided

Dr Vivi Miriagou was born in 1964, Athens Greece. VM is currently senior researcher in the Laboratory of Bacteriology at the Hellenic Pasteur Institute. She has received her Bsc (Biology) in 1987 from the National & Kapodistrian University of Athens. She has received her PhD in Microbiology in 1997 from the Aristotelian University of Thessaloniki. In 2001 she joined the Laboratory of Bacteriology of the Hellenic Pasteur Institute and since 2006 she has been appointed researcher in the same laboratory. She participates in the research projects of the laboratory on Bacterial Antibiotic Resistance and is responsible for the activities on the genetics of resistance to newer -lactams. Her main research interests are (a) the biochemical and molecular characterization of determinants encoding for beta-lactamases, enzymes that hydrolyze the beta-lactam antibiotics, (b) the delineation of the enzymatic mechanism of hydrolysis of beta-lactam antibiotics by beta-lactamases, (c) the investigation of the expression, mobilization and clustering of resistance determinants, and (d) the characterization of genetic units, such as mutli-resistant plasmids, carrying resistance genes. Also modeling of resistance enzymes and complexes with the respective antibiotics has been introduced in the laboratory under her supervision. She has 109 publications in peer-reviewed international journals (including 4 reviews and one editorial), she is currently on the Editorial Board of two international scientific journals, and has reviewed for an additional 9 journals, and since 2010 she is appointed to work with ECDC as Disease Expert - Laboratory for Greece, in the ECDC-Network for Antimicrobial Resistance-AMR.

Konstantinos Lazaridis is a Researcher at the Department of Immunology of the Hellenic Pasteur Institute. He received his BSc in Biological Sciences from the University of Surrey (2000), and he obtained his PhD from the School of Biological Science of the University of East Anglia (2005). From 2006 to 2018 he worked as a Research Associate at the Laboratory of Neurobiology and Immunology of the Hellenic Pasteur Institute. He has been involved in several research programs, funded by the EU and other international sources related to the construction of protein mutants, their production in various systems such as bacteria, yeast and higher eukaryotic cells, the optimization of culture conditions, their purification and biochemical characterization. His research interests include: 1) the production of proteins involved in autoimmune diseases for the study of pathogenesis or for use as antigen-specific therapeutics, and 2) the production and purification of monoclonal and polyclonal antibodies for use in experimental models of disease and therapeutic applications. He has published 24 articles in international journals, with more than 700 citations and h-index=14 (WoS).

Paraskevi Zisimopoulou is a main researcher, head of the Laboratory of Molecular Neurobiology and Immunology (LMNI), with experience in molecular biology and neuroscience. She holds a Diploma in biology, MSc in biochemistry, cellular biology and immunology, PhD in biochemistry and human genetics. All titles were awarded from the University of Wuerzburg, Germany. She is working in the LMNI since 2004. In the recent years her research interest focuses on the understanding of Myasthenia gravis, neuromyelitis optica and other neuroimmunological diseases. The main objective of the studies is the development of new diagnostic and treatment techniques and the analysis of the pathogenicity of the autoantibodies. She has participated in the development of 5 cell-based techniques for diagnosis while she participates in a patent for the development of a hypersensitive method of Radioimmunoprecipitation.